SEC Form 4 reporting owner

Janku Filip

Janku Filip has filed 9 Form 4 transactions reported between January 2, 2026 and June 30, 2026, as Chief Medical Officer of Monte Rosa Therapeutics, Inc..

Name as filed: Janku Filip

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$467K
3 lines
Companies
1
with Form 4 filings
Latest transaction
Jun 30, 2026
transaction date

Roles and reported holdings

  • GLUEMonte Rosa Therapeutics, Inc.
    Jan 2, 2026 – Jun 30, 2026

    Chief Medical Officer

    Held directly59,992 sh as of Jun 23, 2026 · Form 4

    24 months: $467K sold

Transaction history

All 9 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jun 30, 2026GLUEChief Medical OfficerOption exerciseCode M · direct5,407$73K@ $13.41Form 4
Jun 29, 2026GLUEChief Medical OfficerOption exerciseCode M · direct6,000$45K@ $7.56Form 4
Jun 24, 2026GLUEChief Medical OfficerOption exerciseCode M · direct30,000$227K@ $7.56Form 4
Jun 23, 2026GLUEChief Medical OfficerOpen-market saleCode S · direct11,845$240K@ $20.22Form 4
Jun 23, 2026GLUEChief Medical OfficerOption exerciseCode M · direct6,000$45K@ $7.56Form 4
Feb 23, 2026GLUEChief Medical OfficerOpen-market saleCode S · direct9,189$179K@ $19.50Form 4
Jan 5, 2026GLUEChief Medical OfficerOpen-market saleCode S · directAlso reported by Nickson Philip, Townson Sharon3,155$48K@ $15.17Form 4
Jan 2, 2026GLUEChief Medical OfficerGrant or awardCode A · direct139,000—Form 4
Jan 2, 2026GLUEChief Medical OfficerGrant or awardCode A · direct31,000—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.